1. Home
  2. BCAL vs STTK Comparison

BCAL vs STTK Comparison

Compare BCAL & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern California Bancorp

BCAL

Southern California Bancorp

HOLD

Current Price

$21.86

Market Cap

704.1M

Sector

Finance

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$5.81

Market Cap

652.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCAL
STTK
Founded
2001
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
704.1M
652.4M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
BCAL
STTK
Price
$21.86
$5.81
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
★ $24.75
$15.40
AVG Volume (30 Days)
187.5K
★ 1.2M
Earning Date
10-30-2026
11-05-2026
Dividend Yield
★ 2.22%
N/A
EPS Growth
★ 777.27
53.02
EPS
★ 0.86
N/A
Revenue
N/A
★ $1,000,000.00
Revenue This Year
$1.36
N/A
Revenue Next Year
$6.48
N/A
P/E Ratio
$25.20
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$16.61
$1.72
52 Week High
$22.41
$8.33

Technical Indicators

Market Signals
Indicator
BCAL
STTK
Relative Strength Index (RSI) 52.76 37.90
Support Level $20.52 $3.55
Resistance Level $21.87 $7.66
Average True Range (ATR) 0.40 0.45
MACD 0.01 -0.06
Stochastic Oscillator 68.57 12.31

Price Performance

Historical Comparison
BCAL
STTK

About BCAL Southern California Bancorp

California BanCorp is a relationship-focused community bank offering commercial loan and deposit products, along with other services delivered directly or through strategic alliances, to business and individual customers in its target markets. The Company provides financial products and services to individuals, professionals, and small to medium-sized businesses through its branch and commercial banking offices serving California. Its lending products consist mainly of construction and land development loans, real estate loans, C&I loans, and consumer loans, and it is a Preferred SBA Lender, while its deposit products consist mainly of demand deposit, money market, and certificates of deposit. The Company operates in one reportable segment, commercial banking.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: